KBG syndrome is a rare genetic disorder that requires lifelong management and personalized care. Treatment focuses on addressing specific symptoms and complications as they arise, improving quality of life, and supporting developmental needs. While there is no cure for this condition, a multidisciplinary approach combining standard medical interventions with supportive therapies has shown promise in helping affected individuals reach their full potential. Ongoing research continues to explore new treatment strategies, though most care remains symptom-based rather than disease-modifying.

Understanding Treatment Goals in KBG Syndrome

Managing KBG syndrome presents unique challenges because each person experiences the condition differently. The primary goal of treatment is not to cure the underlying genetic cause, which remains impossible with current medical technology, but rather to improve the day-to-day functioning and overall well-being of affected individuals. This means focusing on controlling symptoms, preventing complications, supporting normal growth and development, and addressing behavioral and learning difficulties that commonly occur.^[1]

Treatment decisions depend heavily on which symptoms a particular person has and how severe those symptoms are. Because KBG syndrome affects multiple body systems including the skeleton, brain, heart, teeth, and digestive system, care usually involves a team of different specialists working together. The medical team might include neurologists for seizures and developmental issues, cardiologists for heart problems, endocrinologists for growth concerns, dentists for dental abnormalities, and therapists to support learning and movement skills.^[2]

Medical societies and expert panels have developed recommendations for how to best care for people with KBG syndrome, though these are based more on clinical experience than on large controlled studies. The rarity of the condition means that treatment approaches are often adapted from what works for similar syndromes or specific symptoms. Parents and caregivers play a crucial role in coordinating care and ensuring that all of a person’s needs are addressed throughout their lifetime.^[6]

Standard Treatment Approaches

The foundation of KBG syndrome management involves treating each symptom as it appears and preventing known complications. This symptom-based approach requires regular monitoring and intervention at different life stages. From infancy through adulthood, affected individuals need coordinated care that evolves with their changing needs.^[2]

Feeding difficulties are common in infancy and may require special interventions. Some babies cannot feed normally and need nasogastric tubes, which are thin tubes placed through the nose into the stomach to deliver nutrition. This ensures adequate calorie intake during a critical period of growth and development. As children grow older, many develop gastroesophageal reflux disease, a condition where stomach contents flow back into the esophagus causing discomfort. Medications that reduce stomach acid production or increase the speed at which the stomach empties are commonly prescribed to manage this problem.^[7]

Palatal abnormalities, which are structural problems with the roof of the mouth, occur in some individuals with KBG syndrome. These may require surgical correction to improve feeding, speech, and prevent ear infections. After surgery, speech therapy often becomes necessary to help develop clear communication skills. The therapy may continue for years, as children work on articulation, language development, and social communication.^[2]

Hearing loss affects many people with KBG syndrome and takes different forms including conductive hearing loss (where sound cannot reach the inner ear efficiently), sensorineural hearing loss (where the inner ear or nerve pathways are damaged), or mixed hearing loss (a combination of both). Recurrent middle ear infections called otitis media are particularly common and contribute to conductive hearing problems. Treatment typically begins with pressure-equalizing tubes surgically placed through the eardrum to allow fluid drainage and reduce infection frequency. Some children also need surgical removal of the tonsils and adenoids to improve breathing and reduce ear infections. When hearing loss persists despite these interventions, hearing aids or other amplification devices may be recommended.^[7]

Seizures develop in some individuals with KBG syndrome and require standard anticonvulsant medications. The specific drug chosen depends on the type of seizures, their frequency, and how the person responds to treatment. Common anticonvulsant medications include drugs like levetiracetam, valproic acid, or carbamazepine. Some people achieve good seizure control with a single medication, while others need combinations of drugs. Regular monitoring through blood tests ensures medication levels remain therapeutic, and electroencephalogram (EEG) testing helps assess brain electrical activity and guide treatment adjustments.^[7]

Short stature is one of the most consistent features of KBG syndrome, with approximately two-thirds of affected individuals having height below the tenth percentile for their age. Growth hormone therapy represents a potential treatment option for those with significant growth impairment. Before starting treatment, doctors perform stimulation tests where substances like arginine or clonidine are given to trigger growth hormone release, and blood samples measure the response. They also check levels of insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3), which reflect growth hormone activity in the body.^[9]

When growth hormone therapy is initiated, synthetic growth hormone is injected under the skin, typically daily. The treatment aims to improve growth velocity, which is how many centimeters a child grows per year. Studies have shown that some children with KBG syndrome respond well to growth hormone therapy, with improved growth rates during treatment. However, not all individuals benefit equally, and the treatment requires careful monitoring of height, bone age (determined by hand X-rays), and pubertal development. Some children also develop premature puberty, which can be treated with medications that temporarily suppress puberty to allow more time for growth before the growth plates in bones close.^[9][12]

Congenital heart defects occur in some people with KBG syndrome, particularly those who have deletions affecting the ANKRD11 gene rather than point mutations within the gene. Standard cardiology care follows established guidelines for the specific heart defect present, whether that involves medications to support heart function, surgical repair, or ongoing monitoring with echocardiograms. Women with KBG syndrome who have heart defects need specialized care during pregnancy, involving both cardiologists and maternal-fetal medicine physicians to ensure safe delivery.^[7]

Developmental delays and intellectual disability are nearly universal in KBG syndrome, ranging from mild to moderate severity. Standard treatment involves early intervention programs starting in infancy, special education services tailored to individual learning needs, and various therapies. Physical therapy addresses motor skills and muscle strength, occupational therapy works on daily living skills and fine motor coordination, and speech-language therapy targets communication abilities. These interventions continue throughout childhood and often into adulthood, adjusted to meet changing developmental stages.^[2]

Behavioral issues including hyperactivity, anxiety, aggression, and autism spectrum disorder characteristics are recognized as constant features of KBG syndrome. Management typically involves behavioral therapies, educational support, and sometimes psychiatric medications. Drugs used for attention deficit hyperactivity disorder, such as methylphenidate or amphetamine-based medications, may help with attention and hyperactivity. Anxiety might be treated with selective serotonin reuptake inhibitors or other anti-anxiety medications. Behavioral interventions, applied behavior analysis, and social skills training complement pharmacological treatments.^[8]

Regular surveillance forms a critical component of standard care. This includes routine monitoring of hearing through annual audiology tests, vision screening for problems like strabismus (crossed eyes) and refractive errors, growth measurements plotted on growth charts at every medical visit, and assessment of pubertal development in prepubertal individuals to detect early signs of premature puberty. Cognitive development should be evaluated periodically to ensure educational plans remain appropriate and effective.^[7]

Dental care requires special attention because macrodontia (unusually large teeth, especially the upper central incisors) occurs in about eighty percent of people with KBG syndrome. Additional dental problems include missing teeth, premature tooth loss in adults, and enamel hypoplasia where tooth enamel forms improperly. Regular dental visits, good oral hygiene, and sometimes orthodontic treatment help maintain dental health. Some individuals need tooth extractions or other dental procedures to address crowding or structural problems.^[8]

Emerging Research and Clinical Trial Perspectives

Research into KBG syndrome remains limited due to the rarity of the condition, with fewer than two hundred cases reported in medical literature, though many more likely exist undiagnosed. Current understanding focuses primarily on the genetic cause, a mutation or deletion affecting the ANKRD11 gene, and how this leads to the diverse symptoms observed. The ANKRD11 protein functions as a chromatin regulator, controlling how tightly DNA is packaged and which genes are turned on or off, particularly important in brain development and bone formation.^[8]

No specific clinical trials targeting KBG syndrome treatments are currently underway or reported in the medical literature. The small number of affected individuals worldwide makes organizing traditional randomized controlled trials extremely challenging. Instead, research efforts concentrate on understanding the basic biology of the ANKRD11 gene and protein, hoping this knowledge will eventually point toward targeted therapies.^[4]

Scientists have discovered that ANKRD11 plays a crucial role in neural development and the ability of neurons to change and adapt, a property called plasticity that underlies learning and memory. The protein appears to control histone acetylation, a chemical modification that affects how genes are expressed. When ANKRD11 function is reduced, as happens in KBG syndrome, gene expression patterns change in ways that affect brain development, bone formation, and multiple other body systems. Understanding these molecular pathways represents the first step toward developing therapies that might address the root cause rather than just symptoms.^[1][8]

The identification of ANKRD11 as one of the most frequently mutated genes in patients with neurodevelopmental disorders diagnosed through whole exome sequencing has increased research interest. Whole exome sequencing analyzes the protein-coding portions of all genes simultaneously, allowing discovery of disease-causing mutations without knowing in advance which gene to examine. This technology has dramatically improved diagnosis rates and revealed that KBG syndrome might be more common than previously thought, simply underdiagnosed due to variable and sometimes mild presentations.^[8]

Research into growth hormone therapy effectiveness in KBG syndrome represents one area where clinical data is slowly accumulating. Case reports and small case series have documented experiences with growth hormone treatment, showing that some children respond with improved growth velocity and increased final height. One published case report described a girl with KBG syndrome who received growth hormone therapy after her peak growth hormone response to stimulation tests was low. During the first year of treatment, her height increased by nearly one standard deviation, and after two years, she had moved from significantly below average height to closer to the normal range.^[9]

However, these reports involve only a handful of patients, and no systematic studies have compared growth hormone therapy in KBG syndrome to placebo or no treatment. The optimal timing for starting treatment, appropriate dosing, duration of therapy, and which patients are most likely to benefit remain unclear. Some children enter puberty early, which complicates treatment because early puberty causes growth plates to close sooner, limiting final height. Combining growth hormone therapy with puberty-blocking medications has been tried in some cases, but evidence for this approach remains anecdotal.^[12]

The variability in clinical presentation even among family members carrying the same ANKRD11 mutation suggests that other genetic or environmental factors modify the syndrome’s severity. Research identifying these modifying factors could reveal new treatment targets. For instance, if certain genes or proteins can partially compensate for ANKRD11 deficiency, enhancing their activity might reduce symptoms.^[6]

Patient registries represent an important research tool for rare diseases like KBG syndrome. Organizations like the KBG Syndrome Association maintain registries where affected individuals and families can share medical information, creating a database that researchers can use to identify patterns, track natural history, and potentially recruit participants for future studies. These registries help characterize the full spectrum of the condition, including less common features that might not be apparent in published case reports.^[3]

Genetic counseling and prenatal testing have advanced significantly, allowing families to make informed reproductive decisions. When a pathogenic ANKRD11 variant has been identified in a family member, prenatal testing through amniocentesis or chorionic villus sampling can determine whether a pregnancy is affected. Preimplantation genetic testing, where embryos created through in vitro fertilization are tested before transfer to the uterus, offers another option for couples wanting to avoid passing the condition to their children. These technologies do not treat KBG syndrome but provide families with choices about family planning.^[7]

Gene therapy, a treatment approach where functioning genes are introduced into cells to compensate for abnormal genes, remains purely theoretical for KBG syndrome. The ANKRD11 gene is large and complex, making it technically challenging to package into delivery systems like viral vectors commonly used in gene therapy. Additionally, the timing and level of ANKRD11 expression appear critical for normal development, so simply adding more of the protein might not achieve the desired effects or could even cause harm. These scientific hurdles mean gene therapy for KBG syndrome lies far in the future if it becomes possible at all.^[1]

Research comparing KBG syndrome to other genetic conditions with overlapping features, such as Cornelia de Lange syndrome, might reveal common biological pathways that could be targeted therapeutically. Both conditions involve chromatin regulation and share some clinical features including developmental delay, distinctive facial features, and skeletal abnormalities. If researchers identify drugs that help one condition by targeting shared mechanisms, those drugs might benefit the other as well.^[4]

Most Common Treatment Methods

• Surgical Interventions
  • Surgical corrections for palatal abnormalities to improve feeding and speech
  • Placement of pressure-equalizing tubes for chronic middle ear infections
  • Tonsillectomy and adenoidectomy to reduce infection frequency and improve breathing
  • Correction of undescended testicles in affected males
  • Surgical repair of congenital heart defects when present
  • Orthodontic procedures and tooth extractions to address dental crowding from macrodontia
• Pharmacological Treatments
  • Anticonvulsant medications such as levetiracetam, valproic acid, or carbamazepine for seizure control
  • Medications to reduce stomach acid production for gastroesophageal reflux disease
  • Stimulant medications like methylphenidate for attention deficit and hyperactivity
  • Selective serotonin reuptake inhibitors or other medications for anxiety management
  • Medications to suppress early puberty in cases of premature pubertal development
• Growth Hormone Therapy
  • Daily subcutaneous injections of synthetic growth hormone for significant short stature
  • Monitoring of growth velocity and bone age during treatment
  • Assessment through stimulation tests before initiating therapy
• Supportive Feeding Methods
  • Nasogastric tube feeding for infants with severe feeding difficulties
  • Specialized feeding techniques and positioning to prevent aspiration
  • Nutritional supplementation to ensure adequate calorie intake
• Hearing Support
  • Hearing aids or amplification devices for persistent hearing loss
  • Regular audiological monitoring to detect changes in hearing status
  • Treatment of recurrent ear infections to preserve hearing function
• Therapeutic Interventions
  • Physical therapy to improve motor skills and muscle strength
  • Occupational therapy focusing on daily living skills and fine motor coordination
  • Speech-language therapy for communication development and articulation
  • Behavioral therapy and applied behavior analysis for behavioral challenges
  • Social skills training to support interaction and relationship development
• Educational Support
  • Early intervention programs starting in infancy for developmental delays
  • Individualized education plans tailored to specific learning needs
  • Special education services throughout school years
  • Transition planning for adult life and vocational training
• Multidisciplinary Monitoring
  • Regular assessment by multiple specialists including neurologists, cardiologists, and endocrinologists
  • Annual hearing and vision screening
  • Growth measurements at every medical visit
  • Pubertal development monitoring in prepubertal individuals
  • Periodic cognitive and developmental evaluations